[DPHARMA] QoQ Cumulative Quarter Result on 30-Sep-2014 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
21-Nov-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Sep-2014 [#3]
Profit Trend
QoQ- 54.64%
YoY- 1.65%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Revenue 101,907 45,599 176,961 125,937 81,118 40,495 162,405 -26.76%
PBT 20,605 12,198 46,509 32,589 21,302 11,175 40,175 -36.00%
Tax -5,788 -3,229 0 -8,014 -5,410 -2,810 -7,900 -18.77%
NP 14,817 8,969 46,509 24,575 15,892 8,365 32,275 -40.57%
-
NP to SH 14,817 8,969 35,271 24,575 15,892 8,365 32,275 -40.57%
-
Tax Rate 28.09% 26.47% 0.00% 24.59% 25.40% 25.15% 19.66% -
Total Cost 87,090 36,630 130,452 101,362 65,226 32,130 130,130 -23.54%
-
Net Worth 190,284 205,045 192,942 187,436 179,045 190,050 181,850 3.07%
Dividend
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Div 5,596 - 25,679 5,553 5,551 - 24,293 -62.52%
Div Payout % 37.77% - 72.81% 22.60% 34.93% - 75.27% -
Equity
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Net Worth 190,284 205,045 192,942 187,436 179,045 190,050 181,850 3.07%
NOSH 139,915 139,486 138,807 138,841 138,794 138,723 138,817 0.52%
Ratio Analysis
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
NP Margin 14.54% 19.67% 26.28% 19.51% 19.59% 20.66% 19.87% -
ROE 7.79% 4.37% 18.28% 13.11% 8.88% 4.40% 17.75% -
Per Share
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
RPS 72.83 32.69 127.49 90.71 58.44 29.19 116.99 -27.15%
EPS 10.59 6.43 25.41 17.70 11.45 6.03 23.25 -40.88%
DPS 4.00 0.00 18.50 4.00 4.00 0.00 17.50 -62.71%
NAPS 1.36 1.47 1.39 1.35 1.29 1.37 1.31 2.53%
Adjusted Per Share Value based on latest NOSH - 138,912
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
RPS 10.59 4.74 18.40 13.09 8.43 4.21 16.88 -26.77%
EPS 1.54 0.93 3.67 2.55 1.65 0.87 3.36 -40.63%
DPS 0.58 0.00 2.67 0.58 0.58 0.00 2.53 -62.64%
NAPS 0.1978 0.2132 0.2006 0.1949 0.1861 0.1976 0.189 3.08%
Price Multiplier on Financial Quarter End Date
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Date 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 -
Price 2.65 3.88 2.50 3.17 2.97 3.03 2.58 -
P/RPS 3.64 11.87 1.96 3.49 5.08 10.38 2.21 39.59%
P/EPS 25.02 60.34 9.84 17.91 25.94 50.25 11.10 72.16%
EY 4.00 1.66 10.16 5.58 3.86 1.99 9.01 -41.89%
DY 1.51 0.00 7.40 1.26 1.35 0.00 6.78 -63.35%
P/NAPS 1.95 2.64 1.80 2.35 2.30 2.21 1.97 -0.67%
Price Multiplier on Announcement Date
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Date 25/08/15 18/05/15 24/02/15 21/11/14 26/08/14 20/05/14 26/02/14 -
Price 2.40 3.90 2.92 3.01 3.37 3.09 2.60 -
P/RPS 3.30 11.93 2.29 3.32 5.77 10.59 2.22 30.34%
P/EPS 22.66 60.65 11.49 17.01 29.43 51.24 11.18 60.36%
EY 4.41 1.65 8.70 5.88 3.40 1.95 8.94 -37.64%
DY 1.67 0.00 6.34 1.33 1.19 0.00 6.73 -60.61%
P/NAPS 1.76 2.65 2.10 2.23 2.61 2.26 1.98 -7.57%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment